Search results
Johnson & Johnson to acquire Proteologix for $850 million
Reuters via Yahoo Singapore Finance· 2 months agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...
Johnson & Johnson forecasts as much as 6% sales growth in 2024
Reuters via Yahoo Singapore Finance· 7 months ago(Reuters) -Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full...
Johnson & Johnson to submit application to start trials for its robotic surgical system
Reuters via Yahoo Singapore Finance· 8 months agoNov 7 (Reuters) - Johnson & Johnson MedTech unit said on Tuesday it would submit an application to the U.S. Food & Drug Administration in the second half of 2024 to initiate clinical trials ...
UPDATE 1-Johnson & Johnson to submit application to start trials for surgical robot
Reuters via Yahoo Singapore Finance· 8 months agoJohnson & Johnson's MedTech unit said on Tuesday it would submit an application to the U.S. Food & Drug Administration in the second half of 2024 to initiate clinical trials of its robotic surgical ...
Factbox-Some of the biggest splits in Corporate America
Reuters via Yahoo Singapore Finance· 1 month ago(Reuters) - Chemical maker DuPont has become the latest multinational to break up its business,...
J&J to hold 9.5% stake in Kenvue after share exchange offer
Reuters via Yahoo News Singapore· 10 months agoShares of the consumer health company rose 1.4% in premarket trading. J&J launched the exchange...
How to watch cricket in the US: Where to stream the 2024 ICC Men’s T20 World Cup today
Yahoo Sports· 1 month agoAaron Jones and the USA cricket team play India this week in the ICC Men's T20 World Cup. (AP...
US FDA classifies recall of Abiomed's blood pumps as most serious
Reuters via Yahoo Singapore Finance· 3 months agoMarch 21 (Reuters) - The U.S. health regulator on Thursday classified the recall of some Impella Left Sided Blood Pumps by Abiomed, a Johnson & Johnson company, as the most serious and said ...
REFILE-U.S. FDA approves Amgen's biosimilar version of J&J's Stelara
Reuters via Yahoo Singapore Finance· 8 months ago(Corrects typo in headline) Oct 31 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis treatment Stelara ...
Astronaut Mom-of-2 Will Join the First All-Civilian Spacewalk While Helping Sick Kids Back Home...
People via Yahoo News Singapore· 1 month agoSpaceX engineer Anna Menon is set to travel deeper into the cosmos than any astronaut has in decades...